FindTrial
Sign In

Add On Effect Of Sariva Churna Orally With Arjun Twak Lepa in Mukhdushika

Assessment Of Add On Effect Of Sariva(Hemidesmus Indicus)Churna Orally with Arjun Twak Lepa In Mukhdushika:Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103299
Enrollment
66
Registered
2026-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

None listed

Sponsors

AMOL BALAJI BIRADAR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS DISPLAYING SYMPTOMS OF MUKHDUSHIKA ACNE VULGARIS STAGES OF COMEDONES AND PAPULES

Exclusion criteria

Exclusion criteria: KNOWN ALLERGIC CONDITION ACNE VULGARIS STAGES OF PUSTULES AND NODULES

Design outcomes

Primary

MeasureTime frame
REDUCTION IN NUMBER OF MUKHDUSHIKA PIDIKA SEVERITY OF MUKHDUSHIKA SHOTHA RUJA DAHATimepoint: 30 Days—

Secondary

MeasureTime frame
CHANGE IN ASSOCIATED SYMPTOMS KANDU DAHATimepoint: 30 Days—

Countries

India

Contacts

Public ContactDR DIGVIJAY L ZAREKAR
digvijay.zarekar61@gmail.com9890908899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026